05.03.2022 ORYZON starts preclinical collaboration on Kabuki syndrome with Kennedy Krieger Institute and Johns Hopkins University MADRID, SPAIN and CAMBRIDGE, MA, UNITED STATES, May 3rd, 2022 – Oryzon Genomics, S.A. (ISIN Code:...
10.22.2021 2021 Virtual Research Conference 2021 Virtual Research Conference Friday & Saturday, October 22-23 We are excited to announce the return...
09.21.2021 Oryzon announces $1 million grant from Kabuki syndrome philanthropists to support a precision medicine Phase I/II trial with Vafidemstat HOPE will be the first clinical trial in precision medicine with vafidemstat in neurodevelopmental diseases...
11.02.2018 2018 KSF Research Conference 2018 KSF Research Conference at Johns Hopkins University Hospital 2018’s conference once again brought together...